Moreover, atypical endometriosis and EAOC may share several molecular alterations such as ARID1A and PIK3CA mutations, PTEN loss, MET amplifications, and HNF1B overexpression, suggesting a common molecular mechanism for malignant development [22–24]. This evidence concerns the gene MET and endometriosis.